|
WO2013186934A1
|
|
Anti-pancreatic-cancer peptide
|
|
US2005226886A1
|
|
Preferential detection of procarboxypeptidase R (thrombin activatable fibrinolyisis inhibitor) by enzyme-linked immunosorbent assay
|
|
JP2008029201A
|
|
Method for preparing stem cell and tissue remedy
|
|
EP1681568A1
|
|
Artificial antibody comprising complementary peptide
|
|
JP2004269520A
|
|
PEPTIDE DEACTIVATING ANAPHYLATOXIN C5a
|
|
AU2003244159A1
|
|
HUMAN IgM ANTIBODY LYSING ACTIVATED LYMPHOCYTES UNDER MEDIATION BY HOMOLOGOUS COMPLEMENT
|
|
JP2004262910A
|
|
Thrombomodulin-inactivating peptide
|
|
JP2003313200A
|
|
Evaluation system for active peptide and new active peptide
|
|
JP2002322199A
|
|
Low molecular peptide inhibiting carboxypeptidase r activity
|
|
JPH09227409A
|
|
Saccharide chain-recognizing antibody and therapeutic agent for hiv
|
|
JPH09241297A
|
|
Detection of antisense homology box in protein molecule
|
|
JPH07196692A
|
|
Oligophagous activity inhibitory factor
|
|
JPH04152889A
|
|
Carboxypeptidase specific to arginine and clinic examination
|
|
US5179198A
|
|
Glycoprotein and gene coding therefor
|
|
JPH02311497A
|
|
New protein and gene to code the same protein
|
|
JPH0222297A
|
|
Novel glycoprotein
|
